Search

The article offers information regarding the Pathways Annual Gathering, an event involving the Canadian Institutes of Health Research (CIHR), First Nations, Indigenous organizations and other partners held at Alberta. Topics discussed include meeting is part of the Pathways to Health Equity for Aboriginal Peoples initiative, aimed at improving health in four areas: mental wellness, diabetes/obesity, oral health and tuberculosis, and views of Carrie Bourassa, scientific director.

The article reports on the decision of the Canadian Institutes of Health Research (CIHR) to cancel its Doctor of Medicine/Doctor of Philosophy (MD/PhD) training program at medical schools across Canada due to budget pressures. An overview of the strategic action plan being developed by CIHR for health research trainees is provided. The need for CIHR to collaboration with universities to enhance career paths of clinician-scientists and its failure to evaluate its training programs are discussed.

The article reports on the call of the blue-ribbon International Review Panel (RIP) to review the lineup of institutes ate the Canadian Institutes of Health Research (CIHR). The chairman of the panel Doctor Eliza Zerhouni mentions that the Governning Council (GC) must examines if the CIHR Institutes's slate are appropriate. Moreover, the recommendations made by the panel for the CIHR is offered.

The article reports that the Canadian Institutes of Health Research (CIHR) plans to develop a Phase I/II interventional trial on the therapeutic validity of balloon venoplasty for multiple sclerosis (MS). It states that the trial seeks to ensure accurate and standardized identification of MS patients. It says that the trial would also assess the measures sensitive to venoplasty outcomes reported by patients.

The article presents a reprint of the article "Research allocations: The long-standing basic/strategic debate," by Roger Collier, published on April 23, 2010 at www.cmaj.ca. It states that research is divided into basic research and strategic research on national health priorities. It adds that funding bodies in Canada varies on how each stream is allocated in which Canadian Institutes of Health Research (CIHR) grants 70% to basic research and 30% to strategic research.

The article reports that the Canadian Institutes of Health Research (CIHR) bolsters support for research tackling Canada's primary health care performance. It states that 36% of Canadians are using hospital emergency departments for their primary health care more than any other industrialized country. Colleen Flood, scientific director of CIHR's Institute of Health Services and Policy Research warns that a dose of strong medicine is needed to tackle gaping deficiencies in the primary care.

The article reports that the Canadian Institutes of Health Research (CIHR) has started campaigning for health research grant applications from social scientists and humanists. It is reported that the Social Sciences and Humanities Research Council is redirecting all grant applications. CIHR is planning important reforms to its peer review system to ensure.

The article reports that the appointment of Pfizer Canada Inc.'s vice-President to the governing council of the Canadian Institutes of Health Research will soon be reviewed by the parliamentary health committee. It is stated that the appointment was announced on October 5, 2009 by the Health Minister Leona Aglukkaq. Patricia Baird, professor in the department of medical genetics at the University of British Columbia remarked the appointment as surprising and inappropriate.

The article informs that the appointment of Bernard Prigent, vice president and medical director of Pfizer Canada Inc., to the Canadian Institutes of Health Research (CIHR) council has raised concern among physicians. According to Sidney Wolfe, director, Washington, DC-based Public Citizen, it is a conflict of interest to appoint him to the council, as the council might get influenced by the industry. Prigent is the first from drug industry to be appointed to the CIHR.

The article informs that according to an analysis of the health-related legal challenges based on the Canadian Charter of Rights and Freedoms, even failed bids can prove beneficial. According to Colleen Flood, scientific director, Canadian Institutes of Health Research's Institute of Health Services and Policy Research, some of the successful cases are ultimately underenforced, whereas some unsuccessful cases lead to policy changes favoring the litigants.

The article presents a reprint of the article "Correcting the CIHR course," by Wayne Kondro, which appeared on September 29, 2009 at www.cmaj.ca last. It notes that Dr. Alain Beaudet, president of Canadian Institutes of Health Research (CIHR), is not enthusiastic on CIHR's strategic plan. Beaudet argues that the plan has an indefinite content and says that it will affect health care. He suggests focusing on strategic and thematic research needed by the country.

The article presents an essay, in which the author offers information on his research work on the use of male circumcision for preventing the transmission of HIV infection. The author informs that the research was funded by the Canadian Institutes of Health Research and the U.S. National Institutes of Health and mentions that randomized clinical trials were conducted on uncircumcised men in Kenya. The research showed a fall of 56% in the transmission of HIV due to male circumcision.

The article focuses on various health-related research works in Canada, that have been selected winners of the competition conducted by the Canadian Institutes of Health Research (CIHR) and Canadian Medical Association Journal (CMAJ). A research focused on use of bovine lipid extract to treat acute respiratory distress syndrome and another revealed the benefits of arthroscopy for osteoarthritis. Another research was based on the early treatment of myocardial infarction.

The article offers information on the competition conducted by the Canadian Institutes of Health Research (CIHR) and Canadian Medical Association Journal (CMAJ) to acknowledge research on medical care in Canada. Researchers were asked to submit research works in various categories including biomedicine, and health services. Winners of the competition include an essay on male circumcision in preventing HIV transmission, and another on the care of patients with myocardial infarction.

This article reports that the Canadian Institutes of Health Research (CIHR) will reorganize grant programs under its open-funding envelope to encourage more research and to simplify the process of writing and reviewing grant applications. The grant programs will be reorganized into short-term project grants for research with a specific goal and long-term foundation grants for researchers with records of excellence. CIHR will also cancel its committee-based peer-review structure.

The article offers information on the Phase II and III clinical trials in Canada by the Canadian Institutes of Health Research (CIHR). It mentions that CIRH hopes to slash the startup times of the clinical trials through the introduction of a standard plate for agreements between the sponsors and researchers. It also notes that the federal granting council has urged the use of a clinical trial template agreement to boil own the relationship and obligations of all parties.

The article focuses on the Drug Safety and Effectiveness Network, a post-market drug surveillance project created by Health Canada and the Canadian Institutes of Health Research. It informs that the project consists of three main components which include a virtual network of centres of excellence in post-market drug research, a coordinating office to manage network operations and a steering committee to provide strategic direction. It also discusses the main objectives of the project.

A letter to the editor is presented in response to the article "CIHR Appointment Stirs Controversy," by A. Silversides in a previous issue.

A letter to the editor is presented in response to article "Federal Committee to Review Pfizer V-P Appointment to CIHR council," by A. Silversides in the November 9, 2009 issue.

Reports on a celebration of the achievement of Health Canada's National Health Research and Development Program (NHRDP) which closed in December, 2000. How the program helped develop comprehensive research and training programs; Plans for the Canadian Institutes of Health Research (CIHR) to take over several functions of the NHRDP; Intention of the CIHR to bring together researchers from different disciplines.